Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05999929 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Memory Support System Feasibility Study

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Dec 31, 2026 → Mar 31, 2027
See other at-risk trials from Bruyère Health Research Institute.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 31, 2026 to Mar 31, 2027 Show 4 more changesShow less
    • Study completion pushed from Mar 31, 2027 to Apr 30, 2027
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 8 of 8 entries
    • Site contact updated
  2. Primary completion date: Mar 31, 2026 to Dec 31, 2026
    • Study completion date: Apr 30, 2026 to Mar 31, 2027
    v4
  3. Primary completion date: Aug 31, 2025 to Mar 31, 2026
    • Study completion date: Aug 31, 2025 to Apr 30, 2026
    • Study site revised
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Mar 31, 2025 to Aug 31, 2025
    • Start date changed from estimate of Sep 2023 to Dec 17, 2023
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determining the feasibility of providing the Memory Support System (MSS) to individuals with mild cognitive impairment (MCI) and their partners at a clinic in Ontario, Canada. This will involve a) collecting information from patients referred to the a memory clinic and geriatric day hospital about the patient's interest in and the patient's preferred method to administer the MSS; and b) a cost analysis related to implementation of the MSS. The study will also measure efficacy outcomes of the MSS regarding program adherence as well as to self-reported IADLs, self-efficacy for memory, quality of life, mood, anxiety, and caregiver burden among a sample of individuals with MCI and their care partners
Trial Details
NCT Number NCT05999929
Lead Sponsor Bruyère Health Research Institute.
Collaborators: Ottawa Hospital Research Institute
Conditions
(from sponsor)		 Mild Cognitive Impairment
Related terms Cognitive Dysfunction
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov